Erasca, Inc. (ERAS)
17.61
-0.02
(-0.11%)
USD |
NASDAQ |
Aug 24, 16:00
17.61
0.00 (0.00%)
After-Hours: 19:19
Erasca Price to Book Value : 15.21 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 15.23 |
| August 20, 2026 | 14.75 |
| August 19, 2026 | 15.61 |
| August 18, 2026 | 15.63 |
| August 17, 2026 | 15.79 |
| August 14, 2026 | 15.88 |
| August 13, 2026 | 15.43 |
| August 12, 2026 | 16.05 |
| August 11, 2026 | 15.81 |
| August 10, 2026 | 15.65 |
| August 07, 2026 | 15.90 |
| August 06, 2026 | 15.78 |
| August 05, 2026 | 16.08 |
| August 04, 2026 | 15.88 |
| August 03, 2026 | 15.41 |
| July 31, 2026 | 15.68 |
| July 30, 2026 | 16.13 |
| July 29, 2026 | 15.31 |
| July 28, 2026 | 15.69 |
| July 27, 2026 | 16.30 |
| July 24, 2026 | 16.51 |
| July 23, 2026 | 16.70 |
| July 22, 2026 | 16.85 |
| July 21, 2026 | 16.74 |
| July 20, 2026 | 16.26 |
| Date | Value |
|---|---|
| July 17, 2026 | 16.56 |
| July 16, 2026 | 16.43 |
| July 15, 2026 | 18.36 |
| July 14, 2026 | 16.84 |
| July 13, 2026 | 15.46 |
| July 10, 2026 | 16.00 |
| July 09, 2026 | 16.57 |
| July 08, 2026 | 16.30 |
| July 07, 2026 | 15.86 |
| July 06, 2026 | 16.28 |
| July 02, 2026 | 15.95 |
| July 01, 2026 | 15.48 |
| June 30, 2026 | 15.82 |
| June 29, 2026 | 14.45 |
| June 26, 2026 | 12.64 |
| June 25, 2026 | 11.81 |
| June 24, 2026 | 11.89 |
| June 23, 2026 | 11.90 |
| June 22, 2026 | 11.91 |
| June 18, 2026 | 10.80 |
| June 17, 2026 | 11.04 |
| June 16, 2026 | 10.57 |
| June 15, 2026 | 11.40 |
| June 12, 2026 | 11.10 |
| June 11, 2026 | 11.06 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Revolution Medicines, Inc. | 17.39 |
| Tango Therapeutics, Inc. | 4.030 |
| Cogent Biosciences, Inc. | 13.30 |
| Apogee Therapeutics, Inc. | 8.502 |
| Arrowhead Pharmaceuticals, Inc. | 26.30 |
Price to Book Value Related Metrics
| PEG Ratio | -0.1668 |
| Price | 17.61 |
| Earnings Yield | -5.42% |
| Market Cap | 5.504B |
| PEGY Ratio | -0.1668 |